GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells

Mitsuru Abe1, Koji Hasegawa, Hiromichi Wada

  • 1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Abstract

Insights

Activation of Peroxisome proliferator-activated receptor-gamma (PPARgamma) in vascular smooth muscle cells (VSMCs) promotes cell differentiation. This process involves the transcription factor GATA-6, highlighting a novel mechanism for controlling VSMC phenotype.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cardiovascular Research

Background:

  • Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a nuclear receptor influencing cell growth and differentiation.
  • PPARgamma activation inhibits human vascular smooth muscle cell (VSMC) growth, but the underlying mechanism remains unclear.
  • GATA-6, a zinc finger transcription factor, is crucial for maintaining the differentiated state in VSMCs.

Purpose of the Study:

  • To elucidate the mechanism by which PPARgamma activation induces differentiation in VSMCs.
  • To investigate the role of GATA-6 in PPARgamma-mediated VSMC differentiation.

Main Methods:

  • Treatment of VSMCs with PPARgamma ligands (15d-PGJ2 and troglitazone).
  • Assessment of differentiated VSMC markers (smooth muscle myosin heavy chain, alpha-actin).
  • Analysis of smooth muscle myosin heavy chain promoter activity using wild-type and mutant constructs.
  • Measurement of GATA-6 DNA binding activity.

Main Results:

  • PPARgamma ligands induced key markers of VSMC differentiation.
  • Ligand treatment enhanced the activity of the smooth muscle myosin heavy chain promoter, dependent on a GATA-6 binding site.
  • Both tested PPARgamma ligands increased GATA-6 DNA binding activity in VSMCs.

Conclusions:

  • PPARgamma activation drives VSMC differentiation through a GATA-6-dependent transcriptional pathway.
  • This study identifies a novel mechanism involving GATA-6 in PPARgamma-mediated VSMC phenotype regulation.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...